574 related articles for article (PubMed ID: 31129755)
1. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.
Salminen A; Kauppinen A; Kaarniranta K
J Mol Med (Berl); 2019 Aug; 97(8):1049-1064. PubMed ID: 31129755
[TBL] [Abstract][Full Text] [Related]
2. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
Salminen A; Kaarniranta K; Kauppinen A
Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
[TBL] [Abstract][Full Text] [Related]
3. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
Wang Y; Jia A; Bi Y; Wang Y; Liu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan.
Salminen A; Hyttinen JM; Kaarniranta K
J Mol Med (Berl); 2011 Jul; 89(7):667-76. PubMed ID: 21431325
[TBL] [Abstract][Full Text] [Related]
6. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Wang L; Hu D; Xie B; Xie L
Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
[TBL] [Abstract][Full Text] [Related]
8. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
9. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Agresta L; Hoebe KHN; Janssen EM
Front Immunol; 2018; 9():2809. PubMed ID: 30546369
[TBL] [Abstract][Full Text] [Related]
11. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency.
Salminen A; Kaarniranta K; Kauppinen A
Cell Mol Life Sci; 2019 May; 76(10):1901-1918. PubMed ID: 30788516
[TBL] [Abstract][Full Text] [Related]
12. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.
Salminen A; Kaarniranta K; Kauppinen A
Ageing Res Rev; 2018 Dec; 48():1-10. PubMed ID: 30248408
[TBL] [Abstract][Full Text] [Related]
13. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.
Mohammadpour H; MacDonald CR; McCarthy PL; Abrams SI; Repasky EA
Cell Rep; 2021 Oct; 37(4):109883. PubMed ID: 34706232
[TBL] [Abstract][Full Text] [Related]
14. Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
Huang W; Liu Y; Luz A; Berrong M; Meyer JN; Zou Y; Swann E; Sundaramoorthy P; Kang Y; Jauhari S; Lento W; Chao N; Racioppi L
Front Immunol; 2021; 12():754083. PubMed ID: 34712241
[TBL] [Abstract][Full Text] [Related]
15. Connections between Metabolism and Epigenetic Modification in MDSCs.
Dai H; Xu H; Wang S; Ma J
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
[TBL] [Abstract][Full Text] [Related]
16. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.
Chen Z; Yuan R; Hu S; Yuan W; Sun Z
Front Immunol; 2022; 13():817942. PubMed ID: 35154134
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models.
Hammami I; Chen J; Murschel F; Bronte V; De Crescenzo G; Jolicoeur M
BMC Cell Biol; 2012 Jul; 13():18. PubMed ID: 22762146
[TBL] [Abstract][Full Text] [Related]
18. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
[TBL] [Abstract][Full Text] [Related]
20. The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype.
Sun Y; Han X; Shang C; Wang Y; Xu B; Jiang S; Mo Y; Wang D; Ke Y; Zeng X
Cell Death Dis; 2022 Jan; 13(1):36. PubMed ID: 35013108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]